Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.7M
-
Number of holders
-
103
-
Total 13F shares, excl. options
-
30M
-
Shares change
-
+470K
-
Total reported value, excl. options
-
$211M
-
Value change
-
+$3.37M
-
Number of buys
-
41
-
Number of sells
-
-44
-
Price
-
$7.05
Significant Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q4 2021
114 filings reported holding HBIO - HARVARD BIOSCIENCE INC - Common Stock as of Q4 2021.
HARVARD BIOSCIENCE INC - Common Stock (HBIO) has 103 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30M shares
of 44.7M outstanding shares and own 67.17% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.06M shares), Portolan Capital Management, LLC (2.54M shares), PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. (2.17M shares), DIMENSIONAL FUND ADVISORS LP (1.88M shares), ROYCE & ASSOCIATES LP (1.81M shares), VANGUARD GROUP INC (1.71M shares), Granahan Investment Management, LLC (1.66M shares), Harvey Partners, LLC (1.27M shares), ACADIAN ASSET MANAGEMENT LLC (1.14M shares), and RENAISSANCE TECHNOLOGIES LLC (906K shares).
This table shows the top 103 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.